User-Friendly Spirometer and Mobile App for Self-Management and Home Monitoring of Asthma Patients

Completed

Conditions studied: Asthma Acute, Asthma in Children, Asthma Chronic, Asthma Attack

In brief

The primary goal of this proposal is to use an in-home, smartphone-enabled, hand-held spirometer to determine the FEV1% predicted ranges that predict the Yellow Zone threshold.

Key facts

Study ID

NCT03642418

Run by

University of California, San Francisco

People needed

20

Starts

2018-08-13

Expected to finish

2020-01-31

Last updated by the study team

2020-07-15

Who can join

Age: 6 and older, up to 15. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Physician-diagnosed mild or moderate persistent asthma
• On controller therapy [inhaled corticosteroid (ICS), ICS + leukotriene receptor antagonist (LTRA), or ICS + long-acting beta agonist (LABA)] for at least the previous six months
• At least one severe exacerbation requiring systemic corticosteroids in the previous year
• Baseline FEV1 >/= 70% predicted for age, gender, and height according to published reference standards
• Parental consent and the child's assent

You may not qualify if…

• Chronic obstructive respiratory disorder other than asthma (e.g., cystic fibrosis, primary ciliary dyskinesia)
• Severe persistent asthma, as evidenced by any of the following:
• 3 hospitalizations
• 6 severe exacerbations in the previous year on chronic oral corticosteroid therapy daily symptoms
• Inability to perform acceptable spirometry
• History of collapsed lung
• History of syncope with forced exhalation
• Not owning an iOS™ device (e.g., iPhone®, iPod®, or iPad®)
• Lacking access to wireless local area networking (Wi-Fi™)

Where it is running

• UCSF- Benioff Children Hospital — San Francisco, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.